SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations
Open Access
- 28 April 2011
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 32 (7), 760-772
- https://doi.org/10.1002/humu.21492
Abstract
Noonan syndrome (NS) is among the most common nonchromosomal disorders affecting development and growth. NS is caused by aberrant RAS-MAPK signaling and is genetically heterogeneous, which explains, in part, the marked clinical variability documented for this Mendelian trait. Recently, we and others identified SOS1 as a major gene underlying NS. Here, we explored further the spectrum of SOS1 mutations and their associated phenotypic features. Mutation scanning of the entire SOS1 coding sequence allowed the identification of 33 different variants deemed to be of pathological significance, including 16 novel missense changes and in-frame indels. Various mutation clusters destabilizing or altering orientation of regions of the protein predicted to contribute structurally to the maintenance of autoinhibition were identified. Two previously unappreciated clusters predicted to enhance SOS1's recruitment to the plasma membrane, thus promoting a spatial reorientation of domains contributing to inhibition, were also recognized. Genotype–phenotype analysis confirmed our previous observations, establishing a high frequency of ectodermal anomalies and a low prevalence of cognitive impairment and reduced growth. Finally, mutation analysis performed on cohorts of individuals with nonsyndromic pulmonic stenosis, atrial septal defects, and ventricular septal defects excluded a major contribution of germline SOS1 lesions to the isolated occurrence of these cardiac anomalies. Hum Mutat 32:760–772, 2011.Keywords
This publication has 71 references indexed in Scilit:
- Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutationJCI Insight, 2010
- SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesionsEuropean Journal of Human Genetics, 2009
- The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disordersHuman Mutation, 2008
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences of the United States of America, 2001
- Regulation of Sos Activity by Intramolecular InteractionsMolecular and Cellular Biology, 1998
- The role of the PH domain in the signal-dependent membrane targeting of SosThe EMBO Journal, 1997
- Identification of the Mitogen-Activated Protein Kinase Phosphorylation Sites on Human Sosl That Regulate Interaction with Grb2Molecular and Cellular Biology, 1996
- Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathwayCell, 1994
- Cardiologic abnormalities in Noonan syndrome: Phenotypic diagnosis and echocardiographic assessment of 118 patientsJournal of the American College of Cardiology, 1993
- Noonan syndrome.Journal of Medical Genetics, 1987